Newsroom

HARRISBURG, Pa.--(BUSINESS WIRE)--The Retail Energy Supply Association (RESA) today released new findings from a Maryland statewide poll conducted by Gonzales Research & Media Services that show voters are increasingly focused on rising energy costs and strongly support policies that preserve retail energy competition and consumer choice in the market. The poll, conducted among 808 registered Maryland voters between December 21, 2025, and January 6, 2026, finds Maryland voters express overw...

LYON, France--(BUSINESS WIRE)--Regulatory News: Fill Up Média (Paris:ALFUM), leader français de l’affichage digital extérieur sonore sur distributeurs de carburant (code ISIN : FR001400AEM6 – mnémonique : ALFUM), annonce aujourd’hui le bilan semestriel de son contrat de liquidité avec TP Icap Midcap au 31 décembre 2025. Au titre du contrat de liquidité confié par la société FILL UP MEDIA à TP Icap Midcap, à la date du 31 décembre 2025, les moyens suivants figuraient au compte de liquidité : Nom...

TREVIGLIO, Italy & BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has been awarded project contracts for Andujar and Arjona with D.B. Andalucia, a special purpose company developing projects in the renewable sector in Spain. These contracts are part of a previously disclosed agreement, announced on August 19, 2025, under which Anaergia S.r.l. will deliver a comprehensive suite of se...

SAN FRANCISCO--(BUSINESS WIRE)--BIOMAKERS raised an additional $8M to scale its AI-native precision oncology platform, accelerating drug and diagnostic development....

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA, eligible for the PEA-PME scheme), a French-American player specialized in complex spine surgery, offering an integrated pre, intra, and post-operative solution based on a 3D planning software, adaptive implants and related services, today published its annual sales and cash position for the full year to December 31,...

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, Code ISIN : FR0014005I80 / Mnémonique : ALSMA, éligible PEA-PME), une société franco-américaine spécialisée dans la chirurgie rachidienne complexe proposant une solution intégrée pré, intra et postopératoire basée sur un logiciel de planification 3D, des implants adaptatifs et des services associés, publie son chiffre d’affaires annuel ainsi que son n...

ARLINGTON, Va.--(BUSINESS WIRE)--Vannadium was selected as a finalist for SXSW Pitch 2026 in the Smart Data, Security and FinTech category for its AI trust infrastructure platform....

ABU DHABI, Verenigde Arabische Emiraten--(BUSINESS WIRE)--SIRBAI kondigde vandaag de officiële lancering aan van de eerste AI-aangedreven autonome dronezwermtechnologie in het Midden-Oosten op UMEX 2026 - een wereldwijd tentoonstellingsplatform voor onbemande systemen en autonome mogelijkheden - waarmee het bedrijf zijn intrede doet in de defensietechnologiesector. Het platform is ontworpen voor onbemande luchtsystemen (UAS) en maakt het mogelijk dat meerdere drones kunnen samenwerken met een h...

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Healthcare advocates from across Florida will emerge on the state capitol to speak out against drastic cuts to Florida’s AIDS Drug Assistance Program (ADAP), recently announced by the Florida Department of Health (FDOH), that will eliminate access to life-saving medication and healthcare needed by thousands living with HIV/AIDS. Beginning March 1, 2026, Florida ADAP will reduce the Federal Poverty Level (FPL) income eligibility threshold for uninsured clients...

LAS VEGAS--(BUSINESS WIRE)--Sagebrush Health Services, a nonprofit organization serving over 10,000 Nevada patients, has filed a lawsuit against Amgen Inc. (NASDAQ: AMGN), alleging that Amgen acted unlawfully by unilaterally terminating the sale of discounted drugs to Sagebrush’s clinics and improperly retracting millions of dollars in past discounts. These actions, Sagebrush maintains, temporarily prevented it from supplying its clinics with necessary medications from Amgen and other manufactu...